Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.

Beukelman, T., Patkar, N., Saag, K., Tolleson-Rinehart, S., Cron, R., Dewitt, E., et al. (2011). 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features. ARTHRITIS CARE & RESEARCH, 63(4), 465-482 [10.1002/acr.20460].

2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

Ruperto N
2011

Abstract

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.
Articolo in rivista - Review Essay
Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Juvenile Rheumatoid; Humans; Monitoring, Physiologic; Practice Guidelines as Topic; Rheumatology; Societies, Medical; Treatment Outcome; United States
English
2011
63
4
465
482
reserved
Beukelman, T., Patkar, N., Saag, K., Tolleson-Rinehart, S., Cron, R., Dewitt, E., et al. (2011). 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features. ARTHRITIS CARE & RESEARCH, 63(4), 465-482 [10.1002/acr.20460].
File in questo prodotto:
File Dimensione Formato  
Beukelman et al-2011-Arthritis care & research-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 883.38 kB
Formato Adobe PDF
883.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/557824
Citazioni
  • Scopus 723
  • ???jsp.display-item.citation.isi??? 592
Social impact